Status:
RECRUITING
Chinese Atrial Fibrillation Registry
Lead Sponsor:
Beijing Anzhen Hospital
Conditions:
Atrial Fibrillation (AF)
Eligibility:
All Genders
18+ years
Brief Summary
This prospective, observational cohort study aims to establish a long-term registry of adult patients with atrial fibrillation (AF) in China to comprehensively characterize patient profiles and evalua...
Detailed Description
This prospective, multicenter observational registry aims to collect standardized clinical data on adults with atrial fibrillation (AF) across over 30 hospitals in China. The study reflects real-world...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Documented atrial fibrillation episode lasting \>30 seconds confirmed by electrocardiogram (ECG), Holter monitor, implantable cardiac monitor, or wearable ECG device
- Signed informed consent and willingness to participate in follow-up
Exclusion
- Atrial fibrillation due to a reversible cause (e.g., transient secondary AF)
- Presence of comorbid conditions associated with an expected life expectancy of less than 1 year
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2035
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT06987825
Start Date
August 1 2011
End Date
December 31 2035
Last Update
May 23 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China, 100029
2
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310009